Tilray CEO on shares being down, oversupply, U.S. cannabis legislation and Canada expansion plans
Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to discuss the company’s shares being down over the closing 12 months and what headwinds the company is going through.
How illegal dispensaries are a threat to the factual cannabis commerce
The booming commerce of cannabis is what many investors are calling the fresh gold run. But with these seemingly riches comes this actuality: there could be a necessary bigger negate…
Jim Cramer on investing in the cannabis and playing sectors
CNBC’s Jim Cramer and David Faber test in on the cannabis and playing sectors.
Why now would possibly presumably well be the handsome time to gain into the cannabis industry
CNBC’s Melissa Lee sits down with ‘The Change’ to focus on why merchants thinks handsome now would possibly presumably well be an ethical time to gain into cannabis.
Phillip Morris CEO: It be untimely to teach the company will enter the cannabis change
Philip Morris World Andr Calantzopoulos joins ‘Closing Bell’ to talk about the law of nicotine, how the company’s accountability-free sales were impacted by the pandemic and whether or not the…
Cannabis stocks are flying excessive on the course to legalization
Pot stocks waft elevated on legalization hopes. With CNBC’s Julia Boorstin and Melissa Lee, and and the Swiftly Money merchants, Guy Adami, Tim Seymour, Steve Grasso and James McDonald. For…
Cannabis is with out doubt some of the quickest rising industry in the U.S.
April 20 marks the unofficial holiday for marijuana and lawful sales are anticipated to attain $24 billion this yr. CNBC’s Frank Holland experiences. For accept entry to to reside and…
Tilray CEO: Opportunities in medical cannabis are expansive
Tilray’s stock is up on the present time, but serene down 80 p.c from a February excessive. CNBC’s Frank Holland stories on his dialog with Tilray CEO Irwin Simon about…
Aphria length in-between CEO: Curbing Canada’s Cannabis Dim Market | Furious Money | CNBC
Jim Cramer chats with Aprhia length in-between CEO Irwin Simon coming off the cannabis company’s shock earnings file and where the corporate is discovering development in the finest kind weed…